Penbrook Management’s Mesoblast MESO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.34M | Sell |
87,075
-500
| -0.6% | -$8.32K | 1.01% | 28 |
|
|
2025
Q4 | $1.58M | Sell |
87,575
-100
| -0.1% | -$1.72K | 1.09% | 21 |
|
|
2025
Q3 | $1.41M | Sell |
87,675
-87,675
| -50% | -$1.28M | 0.99% | 26 |
|
|
2025
Q2 | $2.05M | Buy |
175,350
+87,675
| +100% | +$982K | 0.77% | 35 |
|
|
2025
Q1 | $1.09M | Sell |
87,675
-3,400
| -4% | -$56K | 0.83% | 30 |
|
|
2024
Q4 | $1.8M | Sell |
91,075
-16,200
| -15% | -$179K | 1.23% | 13 |
|
|
2024
Q3 | $876K | Sell |
107,275
-17,650
| -14% | -$120K | 0.57% | 45 |
|
|
2024
Q2 | $851K | Sell |
124,925
-250
| -0.2% | -$1.71K | 0.52% | 43 |
|
|
2024
Q1 | $627K | Sell |
125,175
-12,500
| -9% | -$26.6K | 0.39% | 56 |
|
|
2023
Q4 | $303K | Sell |
137,675
-5,000
| -4% | -$11.9K | 0.2% | 81 |
|
|
2023
Q3 | $351K | Buy |
142,675
+14,850
| +12% | +$71K | 0.26% | 78 |
|
|
2023
Q2 | $1,000K | Hold |
127,825
| – | – | 0.72% | 32 |
|
|
2023
Q1 | $841K | Hold |
127,825
| – | – | 0.64% | 45 |
|
|
2022
Q4 | $744K | Hold |
127,825
| – | – | 0.63% | 44 |
|
|
2022
Q3 | $651K | Hold |
127,825
| – | – | 0.56% | 50 |
|
|
2022
Q2 | $568K | Sell |
127,825
-100
| -0.1% | -$688 | 0.45% | 60 |
|
|
2022
Q1 | $1.08M | Hold |
127,925
| – | – | 0.7% | 44 |
|
|
2021
Q4 | $1.23M | Buy |
127,925
+4,700
| +4% | +$54.6K | 0.74% | 43 |
|
|
2021
Q3 | $1.48M | Sell |
123,225
-850
| -0.7% | -$11.8K | 0.92% | 38 |
|
|
2021
Q2 | $1.86M | Buy |
124,075
+850
| +0.7% | +$13.3K | 1.11% | 29 |
|
|
2021
Q1 | $2.04M | Sell |
123,225
-550
| -0.4% | -$10.4K | 1.47% | 18 |
|
|
2020
Q4 | $2.1M | Sell |
123,775
-150
| -0.1% | -$3.69K | 1.62% | 14 |
|
|
2020
Q3 | $4.61M | Buy |
123,925
+10,175
| +9% | +$319K | 3.99% | 4 |
|
|
2020
Q2 | $2.59M | Sell |
113,750
-650
| -0.6% | -$13.9K | 2.55% | 6 |
|
|
2020
Q1 | $1M | Sell |
114,400
-1,650
| -1% | -$25.3K | 1.28% | 25 |
|
|
2019
Q4 | $1.71M | Buy |
116,050
+4,400
| +4% | +$56.1K | 1.67% | 15 |
|
|
2019
Q3 | $1.55M | Sell |
111,650
-800
| -0.7% | -$8.81K | 1.68% | 13 |
|
|
2019
Q2 | $1.2M | Buy |
112,450
+300
| +0.3% | +$3.17K | 1.28% | 21 |
|
|
2019
Q1 | $1.18M | Sell |
112,150
-8,300
| -7% | -$75.7K | 1.22% | 25 |
|
|
2018
Q4 | $993K | Buy |
120,450
+7,000
| +6% | +$80.3K | 1.13% | 29 |
|
|
2018
Q3 | $1.85M | Sell |
113,450
-5,450
| -5% | -$69.2K | 1.77% | 13 |
|
|
2018
Q2 | $1.31M | Hold |
118,900
| – | – | 1.26% | 26 |
|
|
2018
Q1 | $1.37M | Sell |
118,900
-14,500
| -11% | -$174K | 1.37% | 20 |
|
|
2017
Q4 | $1.56M | Buy |
+133,400
| New | +$1.51M | 1.4% | 18 |
|
|
2016
Q3 | $134K | Buy |
+15,600
| New | +$146K | 0.14% | 99 |
|
Other funds holding MESO
MGP
Penbrook Management's MESO Position: Q1 2026 in Review
Penbrook Management reduced its Mesoblast (MESO) stake by 0.57% in Q1 2026, selling an estimated $8.32K and leaving 87,075 shares worth $1.34M. The position accounts for 1.01% of the portfolio, ranked #28.
Penbrook Management first reported a position in MESO in Q3 2016 and has held it in 35 quarters since. The position peaked at $4.61M in Q3 2020. 69 funds tracked by Wall St. Rank hold MESO as of Q1 2026.
- Penbrook Management held 87,075 shares of Mesoblast worth $1.34M as of Q1 2026.
- Penbrook Management sold 500 Mesoblast shares in Q1 2026, an estimated $8.32K.
- Mesoblast made up 1.01% of Penbrook Management's portfolio in Q1 2026, its #28 holding.
- Penbrook Management first reported a position in Mesoblast in Q3 2016 and has held it in 35 quarters since.
- Penbrook Management's Mesoblast position peaked at $4.61M in Q3 2020.
- 69 funds tracked by Wall St. Rank held Mesoblast as of Q1 2026.
Based on Penbrook Management's 13F filing for Q1 2026, filed 21 Apr 2026.